Members |
targetComponentId |
Amniotic fluid for organism (& C/S) |
Amniotic fluid sent for culture and sensitivity (situation) |
Amniotic fluid for organism (& C/S) |
Amniotic fluid sent for organism evaluation (situation) |
Amniotic fluid pulmonary surfactant test |
Shake test |
Amniotic fluid pulmonary surfactant test |
Foam stability test |
Amniotic fluid pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
Pulmonary surfactant test |
Amniotic fluid sample |
Amniocentesis fluid sample (specimen) |
Amniotic fluid sample |
Amniotic fluid specimen |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin -amniotic |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin - amniotic |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin -amniotic |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin - amniotic |
amnionperforator, automatisk, flergångs |
Amnihook, device (physical object) |
amnionperforator, engångs |
Amnihook, device (physical object) |
Amniotome, reusable |
Amnihook, device (physical object) |
Amniotome, single-use |
Amnihook, device (physical object) |
Amniotomy at delivery |
Amniotomy at delivery (procedure) |
Amniotomy at delivery |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy at delivery |
Artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Amniotomy at delivery (procedure) |
Amniotomy by nurse |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Sweeping of membrane |
Amniotomy to induce labor |
Amniotomy at delivery (procedure) |
Amniotomy to induce labor |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Surgical induction of labour |
Amoeba species |
Amoeba |
Amoebiasis |
Infection due to Entamoeba histolytica |
Amoebiasis |
Amebic infection |
Amoebiasis |
Amebic dysentery (disorder) |
Amoebiasis affecting skin |
Amebic ulcer of skin (disorder) |
Amoebiasis affecting skin |
Amoebiasis of skin |
biverkning av amoxicillin och kaliumklavulanat |
Adverse reaction to amoxicillin and/or clavulanic acid |
amoxicillin + klavulanat |
Product containing amoxicillin and clavulanic acid (medicinal product) |
amfetamin |
Amfetamine |
Amphetamine and cocaine |
Product containing amfetamine (medicinal product) |
Amphetamine and cocaine |
Product containing cocaine (medicinal product) |
Amphetamine or psychostimulant |
Psychostimulant |
Amphetamine or psychostimulant |
Product containing amfetamine (medicinal product) |
överdos av amfetamin |
Amfetamine and/or amfetamine derivative overdose (disorder) |
förgiftning orsakad av amfetamin, med oklar avsikt |
Poisoning caused by amfetamine and/or amfetamine derivative |
Amphotericin (lipid formulation) 50mg powder for infusion solution vial |
Amphotericin B liposome 50 mg powder for solution for injection vial |
amfotericin 100 mg, pulver till infusionsvätska, lösning, flaska |
Amphotericin B only product in parenteral dose form |
amfotericin 100 mg/ml, sockerfri suspension |
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
amfotericin 5 mg/ml, injektionsvätska, suspension, flaska 20 ml |
Amphotericin B only product in parenteral dose form |
amfotericin 5 mg/ml, infusionskoncentrat, flaska 20 ml |
Amphotericin B only product in parenteral dose form |
biverkning av ampicillin och flucloxacillin |
Adverse reaction to ampicillin and/or flucloxacillin (disorder) |
biverkning av ampicillin och kloxacillin |
Adverse reaction to ampicillin and/or cloxacillin |
ampicillin + sulbaktam |
Product containing ampicillin and sulbactam (medicinal product) |
Ampicillin with sulbactam |
Sulbactam |
Ampicillin with sulbactam |
Ampicillin (substance) |
amputerat ben |
Amputated lower limb (finding) |
fördröjd traumatisk amputation av struktur |
Amputated structure, delayed |
Amputation of arm through wrist |
Disarticulation at wrist |
Amputation of arm through wrist |
Amputation of arm through wrist (procedure) |
Amputation of cervix |
Amputation of cervix (procedure) |
Amputation of cervix |
Cervix excision |
Amputation of cervix |
Amputation of cervix (procedure) |
Amputation of cervix |
Cervix excision |
Amputation of foot: [Hey] or [NOS] |
Amputation of the foot |
Amputation of leg |
Amputation of lower limb (procedure) |
Amputation of leg |
Amputation of leg through tibia and fibula |
Amputation of lower limb (& disarticulation) |
Disarticulation of hip |
Amputation of lower limb (& disarticulation) |
Amputation of leg through tibia and fibula |
Amputation of lower limb (& disarticulation) |
Amputation of lower limb (procedure) |
Amputation of lower limb (& disarticulation) |
Amputation of lower limb (procedure) |
Amputation of toe |
Amputation of toe (procedure) |
Amputation of toe |
Disarticulation of toe |
Amputation of toe |
Amputation of toe (procedure) |
Amputation of toe NOS |
Disarticulation of toe |
Amputation of toe NOS |
Amputation of toe (procedure) |
Amputation of upper arm |
Amputation of upper arm |
Amputation of upper arm |
Above elbow amputation |
Amputation of upper limb (& disarticulation) |
Amputation of arm through shoulder |
Amputation of upper limb (& disarticulation) |
Amputation of upper limb (procedure) |
Amputation through knee |
Through knee amputation |
Amsinckiaart |
Amsinckia |
Amycolatopsisart |
Amycolatopsis |
Amylase + lipase + protease 58500unt/18000unt/58500unt |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
amylas 8 000 enheter + lipas 30 000 enheter + proteas 30 000 enheter, tablett |
Product containing triacylglycerol lipase (medicinal product) |
amylas 8 000 enheter + lipas 30 000 enheter + proteas 30 000 enheter, tablett |
Product containing amylase (medicinal product) |
amylas 8 000 enheter + lipas 30 000 enheter + proteas 30 000 enheter, tablett |
Protease-containing product |
Amyloid polyneuropathy type I |
Familial amyloid polyneuropathy, Jewish type |
Amyloid polyneuropathy type I |
Amyloid polyneuropathy type I (disorder) |
amyloidinlagring i pterygium |
Pterygium |
Amyloidosis, type I |
Amyloid polyneuropathy type I (disorder) |
Amyloidosis, type I |
Familial amyloid polyneuropathy, Jewish type |
Anaemia &/or blood screening |
Anemia screening |
Anaemia &/or blood screening |
Anemia screening |
Anaemia NOS: [other deficiency] or [megaloblastic] |
Deficiency anemias |
Anaemia NOS: [other deficiency] or [megaloblastic] |
Megaloblastic anemia |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Normocytic anemia due to chronic blood loss |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Anemia due to chronic blood loss (disorder) |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Acute posthemorrhagic anemia |
Anaemia/blood screening NOS |
Occult blood screening |
Anaemia/blood screening NOS |
Anemia screening |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Acquired aplastic anemia |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Acquired red cell aplasia |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Pure red cell aplasia |
Anaemia: [acquired aplastic] or [normocytic due to aplasia] |
Normocytic anemia due to aplasia |